课题基金 / 基金详情

Human Immunodeficiency Virus Proteinase

Human Immunodeficiency Virus Proteinase
人类免疫缺陷病毒蛋白酶
批准号:
6510426
负责人:
Ben M. Dunn
金额:
$27.22万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1989
资助国家:
美国
项目状态:
已结题
起止时间:
1989-07-01 至 2005-05-31

项目摘要

项目成果

Ben M. Dunn的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Provided by applicant): Antiretroviral therapy with a combination of RT and PR inhibitors has had a profound effect upon the management of HIV-1 infection. However, under drug pressure, the virus is able to evolve into forms that are resistant to the available drug regimens. Thus, drug resistance has become the most significant challenge to AIDS therapy. We have been studying a pediatric population undergoing a clinical trial with protease inhibitors in combination with RT inhibitors. We have discovered that evolution of the protease sequence is accompanied by evolution of the sequence of the cleavage sites within Gag/Pol, thus affecting the efficiency of processing. Furthermore, the evolution of protease is accompanied by alterations in cleavage specificity. We hypothesize that the Gag/Pol cleavage sites and PR form a functional unit in which sequence evolution may be co- dependent. In our renewal period, we will exploit these discoveries to gain additional understanding of the mechanisms of Gag/Pol processing. To this end, we will pursue the following specific aims: Specific Aim I will analyze natural Gag/Pol alleles for processing phenotype in a bacterial expression developed in the current period of support. We will also map the determinants by preparation of chimeric gag/pol constructs and analyze replication of recombinant virus with natural or chimeric gag/pol regions. Specific Aim 2 will study the growth of recombinant virus in the presence of anti-protease drugs in culture. In addition, new protease alleles will be subcloned and expressed for analysis by studies of substrate specificity using a combinatorial library of substrates, and by analysis of the binding of inhibitors. Specific Aim 3 will study the effects of changes in the sequence of Gag processing sites on the efficiency of processing. We will prepare peptides representing products of Gag/Pol processing and test their ability to inhibit the enzyme. We will also conduct structural analyses of fusions of Gag/Pol proteins with an inactive form of HIV PR in order to determine the role of structural organization in the processing events.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Human Immunodeficiency Virus Proteinase
  • 批准号:
    7846703
  • 项目类别:
  • 资助金额:
    $8.97万
  • 财政年份:
    2009
  • 负责人:
    Ben M. Dunn
  • 依托单位:
NOVEL INHIBITORS OF FUNGAL ASPARTIC PROTEINASES
  • 批准号:
    6626411
  • 项目类别:
  • 资助金额:
    $21.4万
  • 财政年份:
    2001
  • 负责人:
    Ben M. Dunn
  • 依托单位:
NOVEL INHIBITORS OF FUNGAL ASPARTIC PROTEINASES
  • 批准号:
    6312013
  • 项目类别:
  • 资助金额:
    $21.45万
  • 财政年份:
    2001
  • 负责人:
    Ben M. Dunn
  • 依托单位:
NOVEL INHIBITORS OF FUNGAL ASPARTIC PROTEINASES
  • 批准号:
    6488787
  • 项目类别:
  • 资助金额:
    $21.42万
  • 财政年份:
    2001
  • 负责人:
    Ben M. Dunn
  • 依托单位:
海外基金